About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Identify Protein Key to Hepatitis C Virus Replication

by VR Sreeraman on August 17, 2009 at 5:56 PM
Font : A-A+

 Researchers Identify Protein Key to Hepatitis C Virus Replication

Experts at Heidelberg University Hospital in Germany say that they have identified a protein in infected liver cells that is essential for the replication of the hepatitis C virus (HCV).

Writing about their work in the journal Public Library of Science Pathogens, they said that inhibiting the protein was highly efficient in blocking virus replication.

Advertisement

According to background information in the article, over 170 million people worldwide are affected by chronic hepatitis C, and, in up to 80 percent of infections, the virus can not be eliminated but persists in the infected individual.

The report further states that chronically infected persons have a high risk of developing serious liver inflammation, liver cirrhosis, and even a liver cell tumour.
Advertisement

An essential cell factor required for hepatitis C virus replication is cyclophilin, which promotes the proper folding of proteins and the formation of large protein assemblies, adds the report.

The researchers say that they analysed liver cells to determine which variant of cyclophilins is critical for hepatitis C virus replication, and found that blocking cyclophilin A leads complete inhibition of virus replication.

They have also found this cyclophilin to be the target of DEBIO-025, a derivative of the immunosuppressant cyclosporin, which is used primarily in the context of organ transplantation.

The researchers say that two complementary effects are responsible for the inhibition of hepatitis C virus replication: cyclophilin A is required both for the formation of the viral replication machinery and for the activity of a viral enzyme that is essential for the assembly of infectious virus particles.

According to them, inhibiting cyclophilin A with DEBIO-025 thus blocks hepatitis C virus replication from two different sides.

By contrast, blocking cyclophilin B had no effect.

"The therapeutic potential of inhibiting cellular factors essential for virus replication has thus far hardly been tapped. But this approach has the major advantage that resistance arises less frequently and to a lesser extent in comparison to therapies directly targeting viral factors," says Professor Bartenschlager.

Source: ANI
LIN
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Monkeypox Outbreak: What it is, How Does it Spread & the Prevention
Seasonal Allergy Medications
How to Choose the Best Eczema-Friendly Moisturizer for Children?
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Chicken Pox Hepatitis A Hepatitis B Shigellosis Vasculitis Silent Killer Diseases Liver Aplastic Anemia Hepatitis C Diet and Nutrition Tips for Athletes 

Most Popular on Medindia

Turmeric Powder - Health Benefits, Uses & Side Effects Nutam (400mg) (Piracetam) Drug Interaction Checker The Essence of Yoga Sanatogen Post-Nasal Drip Accident and Trauma Care How to Reduce School Bag Weight - Simple Tips Blood Pressure Calculator A-Z Drug Brands in India

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use